Round superconductor wires
    11.
    发明授权

    公开(公告)号:US11901097B2

    公开(公告)日:2024-02-13

    申请号:US17288838

    申请日:2019-10-28

    CPC classification number: H01B12/06

    Abstract: A round superconductor wire and method for fabricating same are disclosed. Embodiments are directed to a round superconductor wire including at least two superconductor tapes wound on a wire former. Each superconductor tape includes: bottom stabilizer and silver layers; substrate disposed above the bottom silver layer; buffer film stack disposed above the substrate; superconductor film disposed above the buffer film stack; top silver layer disposed above the superconductor film; and top stabilizer layer disposed above the top silver layer. At least one of the bottom stabilizer layer, bottom silver layer, substrate, buffer film stack, superconductor film, top silver layer, or top stabilizer layer is of a different width, thickness, or material composition in one of the superconductor tapes than in another of the superconductor tapes. These and other embodiments achieve a round superconductor wire having improved current density in high magnetic field applications when made in small diameters.

    INSTRUCTIONAL TECHNOLOGIES FOR POSITIONING A LOWER LIMB DURING MUSCULAR ACTIVITY AND DETECTING AND TRACKING PERFORMANCE OF A MUSCULAR ACTIVITY

    公开(公告)号:US20240023831A1

    公开(公告)日:2024-01-25

    申请号:US18214369

    申请日:2023-06-26

    Inventor: Marc Hamilton

    CPC classification number: A61B5/1107 A61B5/742 A61B5/6829 A61B5/1121

    Abstract: A soleus contraction measurement system includes a sensor configured to measure rotational movement when positioned on a user's foot with an X-axis oriented laterally across the user's foot, a Y-axis oriented parallel to the user's foot, a Z-axis orthogonal to the X-axis and the Y-axis, and a positive X-axis rotational movement corresponding to an increasing ankle angle, and a memory storing computer-executable instructions for controlling a processor to: measure an X-axis rotational movement, identify a positive X-axis rotational movement as a plantarflexion and a negative X-axis rotational movement as an ankle dorsiflexion, deem the plantarflexion a performed soleus contraction when the plantarflexion is immediately followed by the ankle dorsiflexion for two consecutive cycles of plantarflexion and ankle dorsiflexion, and cause performance information regarding the performed soleus contractions to be communicated.

    SYNTHESIS OF NANO-SIZED ZEOLITES
    16.
    发明公开

    公开(公告)号:US20230399234A1

    公开(公告)日:2023-12-14

    申请号:US18334678

    申请日:2023-06-14

    CPC classification number: C01B39/48 C01P2004/64

    Abstract: Nano-sized zeolites may be prepared using germanium oxide (GeO2) as a component of the overall synthesis composition. This is accomplished by the addition of GeO2 as an inexpensive reagent for the synthesis gel. Most of the Ge is retained in the synthesis mixture and the small amount incorporated in the zeolite solid (Si/Ge>100) does not have an appreciable impact on zeolite acidity or other physicochemical properties. The methods disclosed herein circumvent challenges to prepare nano-sized zeolites having dimensions less than 100 nm.

    DISCOVERY AND USE OF IMMUNOGENIC PEPTIDES FOR THE TREATMENT AND PREVENTION OF CANCERS

    公开(公告)号:US20230338485A1

    公开(公告)日:2023-10-26

    申请号:US18027993

    申请日:2021-09-23

    CPC classification number: A61K39/0011 A61P35/00 A61K2039/53

    Abstract: Embodiments of the present disclosure pertain to methods of treating or preventing a cancer in a subject by administering to the subject an immunogenic peptide and/or a nucleotide sequence that expresses the immunogenic peptide. Thereafter, the administered or expressed immunogenic peptide elicits an immune response against cells associated with the cancer. The immunogenic peptides contain a neoantigenic region and are expressed by chimeric nucleotide sequences derived from cells associated with the cancer. The chimeric nucleotide sequences have a higher prevalence in cancer cells when compared to non-cancer cells. Further embodiments pertain to compositions that include the immunogenic peptides of the present disclosure and/or a nucleotide sequences that express them. Additional embodiments pertain to methods of identifying immunogenic peptides by screening cells associated with a cancer for one or more chimeric nucleotide sequences; identifying peptides expressed by the chimeric nucleotide sequences; and selecting immunogenic peptides from the identified peptides.

Patent Agency Ranking